Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association
about
Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reductionESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryThe clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemiaTriglyceride-rich lipoproteins as a causal factor for cardiovascular diseaseFasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and EuropeanApolipoprotein A-V gene therapy for disease prevention / treatment:a critical analysisEffect of Fructose on Established Lipid Targets: A Systematic Review and Meta-Analysis of Controlled Feeding TrialsVitamin E function and requirements in relation to PUFAFructose-containing sugars and cardiovascular diseaseOrigin and therapy for hypertriglyceridaemia in type 2 diabetesObesity and insulin resistance: an abridged molecular correlationBenefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetesLipids and the endothelium: bidirectional interactionsA review of the effect of omega-3 polyunsaturated fatty acids on blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individualsWhat do we currently know about metabolic syndrome and atrial fibrillation?Residual macrovascular risk in 2013: what have we learned?Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patientsIcosapent ethyl for the treatment of severe hypertriglyceridemia.Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.Regular-Fat Dairy and Human Health: A Synopsis of Symposia Presented in Europe and North America (2014-2015)Relationship between Added Sugars Consumption and Chronic Disease Risk Factors: Current UnderstandingOmega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemiaSevere/Extreme Hypertriglyceridemia and LDL Apheretic Treatment: Review of the Literature, Original FindingsComputationally Modeling Lipid Metabolism and Aging: A Mini-reviewOverview of prescription omega-3 fatty acid products for hypertriglyceridemiaAngiopoietin-like protein 4 inhibition of lipoprotein lipase: evidence for reversible complex formationTriglyceride-rich lipoprotein modulates endothelial vascular cell adhesion molecule (VCAM)-1 expression via differential regulation of endoplasmic reticulum stressNovel PPAR pan agonist, ZBH ameliorates hyperlipidemia and insulin resistance in high fat diet induced hyperlipidemic hamsterLarge-scale metabolomic profiling identifies novel biomarkers for incident coronary heart diseaseModulators of hepatic lipoprotein metabolism identified in a search for small-molecule inducers of tribbles pseudokinase 1 expressionBeneficial effects of omega-3 fatty acids on the consequences of a fructose diet are not mediated by PPAR delta or PGC1 alphaCommon variants associated with plasma triglycerides and risk for coronary artery diseaseA Comparative Overview of Prescription Omega-3 Fatty Acid ProductsTotal physical activity might not be a good measure in the relationship with HDL cholesterol and triglycerides in a multi-ethnic population: a cross-sectional study.Olive oil and postprandial hyperlipidemia: implications for atherosclerosis and metabolic syndrome.Hypertriglyceridemia: the importance of identifying patients at risk.Loss-of-function mutations in APOC3, triglycerides, and coronary diseaseJoint linkage and association analysis with exome sequence data implicates SLC25A40 in hypertriglyceridemia.Circulating sCD36 is associated with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals.Lipid Lowering Therapy to Modify Plaque Microstructures.
P2860
Q21246041-37082201-DEB5-407B-A506-4B03C81C70E3Q22241786-4054F8A9-E607-4429-82BD-CD42890CBF4BQ26738554-83442C76-ACE3-40E1-BC5B-7430530F2182Q26745946-BE94F60F-376A-4AA7-9FF7-34973204A8FAQ26749306-159921B0-9678-402C-9FAE-49598070B9F4Q26775009-149805AB-6FD6-4816-B371-03B66DD2696CQ26781687-466C59DC-730D-43D5-A63D-E0C32F85DD95Q26796303-078CDEE8-EE36-4FB2-921C-FAD5C9E9A057Q26801265-220EB13F-8D17-4F81-A48A-F5F94A1AAACCQ26824004-D7093E9F-FBAA-4B3A-B755-84005B059317Q26825473-12E588EF-E2F6-4628-9FD5-458D6F42A982Q26853571-BB751E44-EDD3-4870-ABF7-295C68C52FF4Q26860086-395894C8-7BA7-49E1-8E81-4A54FBADB048Q26863499-0DEA5280-8EE7-4DDC-BD5F-3204118750CEQ26864437-C0186B63-D263-47F8-BB56-0DBDE6277F44Q26996039-4987F302-77CC-441D-AA4F-4097EBA34FA5Q26996051-435C27C3-D1AA-4674-8FC2-04D5F12D118DQ27686834-68841D1A-EC39-4CC7-B64E-1EEA4851ACECQ27687851-5B62BA66-7365-47DF-873A-9F0672BE5990Q28066150-5AB41BA4-1FE3-4E83-B106-53DC0D25003FQ28073747-FA14B285-B219-4924-A6C4-03C696A755C1Q28076399-DA075E92-BDD9-4461-B4AD-8BD6730819FCQ28082905-C527FF38-2C8A-4A05-BA16-28EA5EFC44C6Q28087689-85523B4B-F744-494E-A498-153963FBA624Q28251391-67F1AB64-B76A-4D21-89D0-0A250E7B151DQ28296885-D6259488-B5C6-4E1C-9F6D-10F2E1266938Q28534549-877812DB-B4A3-4D71-8C27-287ABB296798Q28538170-3D6DFCAA-49C1-4947-9BD4-B1F6AC75DDD9Q28542665-A08BD5F2-BE17-4710-9215-993E30576DD5Q28545029-2521A1EB-52C9-4D51-92C1-B1C4A2EA17C6Q28580880-A9803449-072E-41AA-80E4-6A9D619159B7Q28659915-2E38293E-81D2-4F95-8537-A6A9CB8DEC3FQ28972330-92E844F3-5EAD-458F-A48D-7C4E5CAC9BA4Q29353809-083C0D6C-A755-4554-A9BE-94A33DBD6466Q30240705-89E530F1-199D-4F0A-9DB7-6AFE7A23491CQ30244825-B0CCBF1C-BDD7-42D4-BD5B-7DBB097F01AFQ30408720-40BDB3EE-9E0B-4BF2-8C56-19A7AB2A1E35Q30700100-6868E9F9-09B9-4E0B-B044-D7ABB1DD0236Q33554854-3630DDAD-196B-497E-8811-00CA88D1DFB6Q33567290-26494527-1BBA-4B07-8288-597B57EDA0F8
P2860
Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association
description
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2011
@ast
im Mai 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 24 May 2011)
@en
vedecký článok (publikovaný 2011/05/24)
@sk
vědecký článek publikovaný v roce 2011
@cs
wetenschappelijk artikel (gepubliceerd op 2011/05/24)
@nl
наукова стаття, опублікована в травні 2011
@uk
مقالة علمية (نشرت في 24-5-2011)
@ar
name
Triglycerides and cardiovascul ...... the American Heart Association
@ast
Triglycerides and cardiovascul ...... the American Heart Association
@en
Triglycerides and cardiovascul ...... the American Heart Association
@nl
type
label
Triglycerides and cardiovascul ...... the American Heart Association
@ast
Triglycerides and cardiovascul ...... the American Heart Association
@en
Triglycerides and cardiovascul ...... the American Heart Association
@nl
prefLabel
Triglycerides and cardiovascul ...... the American Heart Association
@ast
Triglycerides and cardiovascul ...... the American Heart Association
@en
Triglycerides and cardiovascul ...... the American Heart Association
@nl
P2093
P50
P3181
P1433
P1476
Triglycerides and cardiovascul ...... the American Heart Association
@en
P2093
Anne Carol Goldberg
Christie Ballantyne
Henry N Ginsberg
Marc S Jacobson
Michael Miller
Neil J Stone
Penny M Kris-Etherton
Subramanian Pennathur
Terry A Lennie
Theodore Mazzone
P304
P356
10.1161/CIR.0B013E3182160726
P407
P577
2011-05-24T00:00:00Z